Back

The Lack of Nrf2 Causes Hepatocyte Dedifferentiation and Reduced Albumin Production in an Experimental Extrahepatic Cholestasis Model

Wang, G.-Y.; Garcia, V.; Lee, J.; Yanum, J.; Jiang, H.; Dai, G.

2021-04-27 pathology
10.1101/2021.04.26.441515 bioRxiv
Show abstract

The transcription factor Nrf2 modulates the initiation and progression of a number of diseases including liver disorders. The aim of this study was to evaluate whether Nrf2 mediates hepatic adaptive responses to cholestasis. Wild-type and Nrf2-null mice were subjected to bile duct ligation (BDL) or a sham operation. Various assessments were performed at different days after surgery. Significant genotype-dependent changes in liver size, biliary ductular reaction, hepatocyte proliferation, and fibrotic response were not observed. However, as cholestasis progressed to Day 15 post-BDL, hepatocytes in the wild-type mice exhibited a tendency to dedifferentiate, indicated by the very weak expression of hepatic progenitor markers: CD133 and fibroblast growth factor-inducible 14 (Fn14). During the same period, Nrf2 deficiency augmented this tendency, manifested by higher CD133 expression, earlier, stronger, and continuous induction of Fn14 expression, and markedly reduced albumin production. Remarkably, as cholestasis advanced to the late stage (40 days after BDL), hepatocytes in the wild-type mice exhibited a Fn14+ phenotype and strikingly upregulated the expression of deleted in malignant brain tumor 1 (DMBT1), a protein essential for epithelial differentiation during development. In contrast, at this stage, hepatocytes in the Nrf2-null mice entirely inhibited the upregulation of DMBT1 expression, displayed a strong CD133+/Fn14+ phenotype indicative of severe dedifferentiation, and persistently reduced albumin production. Collectively, our studies revealed that Nrf2 maintains hepatocytes in the differentiated state potentially via the increased activity of the Nrf2/DMBT1 pathway during cholestasis. These findings enable us to gain novel insight into how hepatocytes respond to cholestasis. New and NoteworthyWe found that, when hepatocytes are exposed to cholestasis, they exhibit a tendency of dedifferentiation. In this case, Nrf2 is highly activated to markedly up-regulate the expression of epithelial differentiation gene DMBT1, which potentially prevent hepatocytes from dedifferentiation. Our findings revealed a plastic property of hepatocytes in response to cholestasis and demonstrated a novel Nrf2/DMBT1 pathway likely controlling this property of hepatocytes.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
American Journal of Physiology-Gastrointestinal and Liver Physiology
11 papers in training set
Top 0.1%
18.7%
2
Hepatology Communications
21 papers in training set
Top 0.1%
12.5%
3
Cellular and Molecular Gastroenterology and Hepatology
41 papers in training set
Top 0.1%
8.4%
4
Gastroenterology
40 papers in training set
Top 0.5%
4.0%
5
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
25 papers in training set
Top 0.1%
3.7%
6
International Journal of Molecular Sciences
453 papers in training set
Top 3%
3.6%
50% of probability mass above
7
The FASEB Journal
175 papers in training set
Top 0.4%
3.1%
8
The FEBS Journal
78 papers in training set
Top 0.1%
3.1%
9
Cell Communication and Signaling
35 papers in training set
Top 0.2%
2.6%
10
Cells
232 papers in training set
Top 2%
1.9%
11
The American Journal of Pathology
31 papers in training set
Top 0.2%
1.8%
12
Journal of Lipid Research
35 papers in training set
Top 0.2%
1.8%
13
Scientific Reports
3102 papers in training set
Top 62%
1.5%
14
Experimental Neurology
57 papers in training set
Top 0.8%
1.3%
15
Gene
41 papers in training set
Top 1%
1.3%
16
Journal of Cellular and Molecular Medicine
18 papers in training set
Top 0.6%
1.2%
17
eLife
5422 papers in training set
Top 49%
1.2%
18
iScience
1063 papers in training set
Top 24%
1.0%
19
PLOS Neglected Tropical Diseases
378 papers in training set
Top 5%
0.9%
20
Hepatology
18 papers in training set
Top 0.3%
0.9%
21
Stem Cell Research & Therapy
30 papers in training set
Top 0.7%
0.9%
22
PLOS ONE
4510 papers in training set
Top 66%
0.8%
23
Cancers
200 papers in training set
Top 4%
0.8%
24
Human Molecular Genetics
130 papers in training set
Top 3%
0.8%
25
Frontiers in Molecular Biosciences
100 papers in training set
Top 5%
0.7%
26
Journal of Cellular Physiology
21 papers in training set
Top 0.7%
0.7%
27
Nature Communications
4913 papers in training set
Top 64%
0.7%
28
PLOS Pathogens
721 papers in training set
Top 10%
0.6%
29
Disease Models & Mechanisms
119 papers in training set
Top 3%
0.6%
30
Cell Death & Disease
126 papers in training set
Top 3%
0.6%